ABT vs PRVA · P/E 25, rev $44.33B vs P/E 135, $2.90B cap
Abbott Laboratories (ABT) versus Privia Health Group Inc (PRVA) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Privia Health Group Inc (PRVA) is a health information services company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
PRVA does not have a complete income-statement cache yet.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. PRVA currently screens at market cap $2.90B and trailing P/E 135.4.
Not investment advice. Open the ABT and PRVA stock pages for the full models.
Not investment advice.